Related references
Note: Only part of the references are listed.Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department
Elodie Portier et al.
RHEUMATOLOGY INTERNATIONAL (2022)
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
Florian Lucasson et al.
RMD OPEN (2022)
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study
Krystel Aouad et al.
RHEUMATOLOGY (2022)
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Daniel Wendling et al.
JOINT BONE SPINE (2022)
Motivators, Barriers, and Opportunity for E-Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study
Laura Passalent et al.
ARTHRITIS CARE & RESEARCH (2022)
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)
Anna Molto et al.
RHEUMATOLOGY (2021)
Association between environmental air pollution and rheumatoid arthritis flares
Giovanni Adami et al.
RHEUMATOLOGY (2021)
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study
Karin Bengtsson et al.
RHEUMATOLOGY (2021)
Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare Questionnaire
Philip S. Helliwell et al.
JOURNAL OF RHEUMATOLOGY (2021)
Predictive Value of Active Sacroiliitis in MRI for Flare Among Chinese Patients with Axial Spondyloarthritis in Remission
Qing Zheng et al.
RHEUMATOLOGY AND THERAPY (2021)
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Anna Molto et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience
Rosemarie Barnett et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2021)
Structural progression in axial spondyloarthritis
Krystel Aouad et al.
JOINT BONE SPINE (2020)
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis
Bianca Bech et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula
I Concepcion Aranda-Valera et al.
RHEUMATOLOGY (2020)
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis?
Krystel Aouad et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
FREQUENCY OF DISEASE FLARES UNDER LONG-TERM ANTI-TNF THERAPY IN PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE ETANERCEPT VERSUS SULFASALAZINE IN EARLY AXIAL SPONDYLOARTHRITIS TRIAL
F. Proft et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
Mireia Moreno et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae
Daniel F. McWilliams et al.
BMC RHEUMATOLOGY (2019)
Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment
Ming-Han Chen et al.
CLINICAL RHEUMATOLOGY (2018)
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study
Robert Landewe et al.
LANCET (2018)
Defining the target: clinical aims in axial spondyloarthritis
Helena Marzo-Ortega et al.
RHEUMATOLOGY (2018)
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS
Anna Molto et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients
Charlotte Jacquemin et al.
JOURNAL OF RHEUMATOLOGY (2017)
Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare
Bruno Fautrel et al.
ARTHRITIS & RHEUMATOLOGY (2017)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort
Carole Desthieux et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Flare in axial spondyloarthritis. The dark side of the outcome
Daniel Wendling et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Flare in spondyloarthritis: Thresholds of disease activity variations
Marie Godfrin-Valnet et al.
JOINT BONE SPINE (2015)
Severe flare as a predictor of poor outcome in ankylosing spondylitis: a cohort study using questionnaire and routine data linkage
Roxanne Cooksey et al.
RHEUMATOLOGY (2015)
Long-Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non-Radiographically Evident Axial Spondyloarthritis Who Experience a Flare
H. Haibel et al.
ARTHRITIS AND RHEUMATISM (2013)
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial
In-Ho Song et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Frequency and characteristics of disease flares in ankylosing spondylitis
Roxanne Cooksey et al.
RHEUMATOLOGY (2010)
Developing a Standardized Definition for Disease Flare in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)
Clifton O. Bingham et al.
JOURNAL OF RHEUMATOLOGY (2009)
Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration
M. A. Stone et al.
RHEUMATOLOGY (2008)
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
J Brandt et al.
RHEUMATOLOGY (2005)
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
X Baraliakos et al.
ARTHRITIS RESEARCH & THERAPY (2005)
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis -: A longitudinal analysis
PMJ Welsing et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy of infliximab in refractory ankylosing spondylitis:: results of a six-month open-label study
M Breban et al.
RHEUMATOLOGY (2002)
Share Paper
